Partial MHC class II constructs as novel immunomodulatory therapy for stroke. Benedek G, Vandenbark AA, Alkayed NJ, Offner H Neurochem Int. 2017 Jul; 107:138-147. PMID: 27773790. Abstract CommentRecommendBookmarkWatch